The DOI matches its Crossref record; 64 of the 64 references it cites were found in a registry or an index.
MYC oncogene overexpression drives renal cell carcinoma in a mouse model through glutamine metabolism
Open accessAbstract
Significance: The absence of appropriate transgenic animal models of renal cell carcinomas (RCCs) has made it difficult to identify and test new therapies for this disease. We developed a new transgenic mouse model of a highly aggressive form of RCC in which tumor growth and regression is conditionally regulated by the MYC oncogene. Using desorption electrospray ionization–mass-spectrometric imaging, we found that certain glycerophosphoglycerols and metabolites of the glutaminolytic pathway were higher in abundance in RCC than in normal kidney tissue. Up-regulation of glutaminolytic genes and proteins was identified by genetic analysis and immunohistochemistry, therefore suggesting that RCC tumors are glutamine addicted. Pharmacological inhibition of glutaminase slowed tumor progression in vivo, which may represent a novel therapeutic route for RCC.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Nevertheless, the specific metabolic importance of glutamine in tumorigenesis and tumor growth has also been reported194–196”
From Glutamine reliance in cell metabolism (2020) · cites this paper as [196]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Jemal, A., Siegel, R., Xu, J., & Ward, E. (2010) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20073 · Cited by 12,596
Trastuzumab-Induced Hepatotoxicity: A Case Report
Vucicevic, D., Carey, E. J., & Karlin, N. J. (2013) · Breast Care · doi:10.1159/000346844 · Cited by 4,432
Brocken, P., van der Heijden, E. H. F. M., Dekhuijzen, P. N. R., Peters-Bax, L., & de Geus‐Oei, L. (2013) · Respiration · doi:10.1159/000347096 · Cited by 4,011
Comprehensive molecular characterization of clear cell renal cell carcinoma
The Cancer Genome Atlas Research Network (2013) · Nature · doi:10.1038/nature12222 · Cited by 3,485
Wallace, D. C. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3365 · Cited by 2,404
Gao, P., Tchernyshyov, I., Chang, T.-C., Lee, Y.-S., Kita, K., Ochi, T., Zeller, K. I., De Marzo, A. M., Van Eyk, J. E., Mendell, J. T., et al. (2009) · Nature · doi:10.1038/nature07823 · Cited by 2,124
Self-citationWise, D. R., DeBerardinis, R. J., Mancuso, A., Sayed, N., Zhang, X.-Y., Pfeiffer, H. K., Nissim, I., Daikhin, E., Yudkoff, M., McMahon, S. B., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0810199105 · Cited by 2,001
Mutations of the VHL tumour suppressor gene in renal carcinoma
Gnarra, J. R., Tory, K., Weng, Y., Schmidt, L., Wei, M. H., Li, H., Latif, F., Liu, S., Chen, F., Duh, F.-M., et al. (1994) · Nature Genetics · doi:10.1038/ng0594-85 · Cited by 1,730
c-Myc Target Genes Involved in Cell Growth, Apoptosis, and Metabolism
Dang, C. V. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.1.1 · Cited by 1,722
Self-citationMutations in SDHD , a Mitochondrial Complex II Gene, in Hereditary Paraganglioma
Baysal, B. E., Ferrell, R. E., Willett-Brozick, J. E., Lawrence, E. C., Myssiorek, D., Bosch, A., Mey, A. V. D., Taschner, P. E. M., Rubinstein, W. S., Myers, E. N., et al. (2000) · Science · doi:10.1126/science.287.5454.848 · Cited by 1,638
Cited by
Sorted by citations
Items 101–200 of 256
Sainero‐Alcolado, L., Garde-Lapido, E., Snaebjornsson, M. T., Schoch, S., Stevens, I., Ruiz-Pérez, M. V., Dyrager, C., Pelechano, V., Axelson, H., Schulze, A., et al. (2024) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2310479121 · Cited by 36
MYC, Metabolic Synthetic Lethality, and Cancer
Hsieh, A. L., & Dang, C. V. (2016) · Recent results in cancer research/Recent Results in Cancer Research · doi:10.1007/978-3-319-42118-6_4 · Cited by 38
Self-citationHaltom, A. R., Hassen, W. E., Hensel, J., Kim, J., Sugimoto, H., Li, B., McAndrews, K. M., Conner, M. R., Kirtley, M. L., Luo, X., et al. (2022) · Extracellular Vesicle · doi:10.1016/j.vesic.2022.100014 · Cited by 36
Mitochondria and CancerPreprint
Kenny, T. C., & Birsoy, K. (2024) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a041534 · Cited by 40
Non-Coding RNAs as Key Regulators of Glutaminolysis in Cancer
Ortiz-Pedraza, Y., Muñoz-Bello, J. O., Olmedo‐Nieva, L., Contreras‐Paredes, A., Martínez-Ramírez, I., Langley, E., & Lizano, M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21082872 · Cited by 34
Cardoso, H. J., Figueira, M. I., Vaz, C. V., Carvalho, T. M. A., Brás, L. A., Madureira, P. A., Oliveira, P. J., Sardão, V. A., & Socorro, S. (2021) · Cellular Oncology · doi:10.1007/s13402-020-00575-9 · Cited by 34
van den Heuvel, C. N. A. M., van Ewijk, A., Zeelen, C., de Bitter, T. J. J., Huynen, M. A., Mulders, P., Oosterwijk, E., & Leenders, W. P. J. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.00117 · Cited by 33
Mateus, I., Feijó, M., Espínola, L. M., Vaz, C. V., Correia, S., & Socorro, S. (2018) · Scientific Reports · doi:10.1038/s41598-018-28668-4 · Cited by 32
The metabolic landscape of urological cancers: New therapeutic perspectives
Miranda‐Gonçalves, V., Lameirinhas, A., Henrique, R., Baltazar, F., & Jerónimo, C. (2020) · Cancer Letters · doi:10.1016/j.canlet.2020.02.034 · Cited by 33
Dhanasekaran, R., Park, J., Yevtodiyenko, A., Bellovin, D. I., Adam, S. J., Rajan, A., Gabay, M., Fernando, H., Arzeno, J., Arjunan, V., et al. (2020) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2020.07.008 · Cited by 32
Self-citationRole of the KEAP1-NRF2 Axis in Renal Cell Carcinoma
Clerici, S., & Boletta, A. (2020) · Cancers · doi:10.3390/cancers12113458 · Cited by 36
MYC Ran Up the Clock: The Complex Interplay between MYC and the Molecular Circadian Clock in Cancer
Burchett, J. B., Knudsen-Clark, A. M., & Altman, B. J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22147761 · Cited by 32
Simultaneous activation and inhibition of autophagy sensitizes cancer cells to chemotherapy
Chi, K.-H., Wang, Y., Huang, Y.-C., Chiang, H.-C., Chi, M., Chi, C., Wang, H.-E., & Kao, S.-J. (2016) · Oncotarget · doi:10.18632/oncotarget.10873 · Cited by 30
Drusian, L., Nigro, E. A., Mannella, V., Pagliarini, R., Pema, M., Costa, A. S. H., Benigni, F., Larcher, A., Chiaravalli, M., Gaude, E., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.06.106 · Cited by 30
Rauth, S., Malafa, M. P., Ponnusamy, M. P., & Batra, S. K. (2024) · Gastroenterology · doi:10.1053/j.gastro.2024.05.005 · Cited by 29
MYCN and PRC1 cooperatively repress docosahexaenoic acid synthesis in neuroblastoma via ELOVL2
Ding, Y., Yang, J., Ma, Y., Yao, T., Chen, X., Ge, S., Wang, L., & Fan, X. (2019) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-019-1492-5 · Cited by 29
Borodinov, N., Lorenz, M., King, S. T., Ievlev, A. V., & Ovchinnikova, O. S. (2020) · npj Computational Materials · doi:10.1038/s41524-020-00357-9 · Cited by 29
Typical Enhancers, Super-Enhancers, and Cancers
Koutsi, M. A., Pouliou, M., Champezou, L., Vatsellas, G., Giannopoulou, A.-I., Piperi, C., & Agelopoulos, M. (2022) · Cancers · doi:10.3390/cancers14184375 · Cited by 28
Recent advances of ambient ionization mass spectrometry imaging in clinical research
Li, N., Nie, H., Jiang, L., Ruan, G., Du, F., & Liu, H. (2020) · Journal of Separation Science · doi:10.1002/jssc.202000273 · Cited by 28
McAnulty, J., & DiFeo, A. V. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21249486 · Cited by 28
TRPC Channels in the Physiology and Pathophysiology of the Renal Tubular System: What Do We Know?
Englisch, C. N., Paulsen, F. P., & Tschernig, T. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms24010181 · Cited by 26
Zhao, Y., Wang, Y., Miao, Z., Liu, Y., & Yang, Q. (2023) · Molecular Biology Reports · doi:10.1007/s11033-023-08495-1 · Cited by 26
Filling the Tank: Keeping Antitumor T Cells Metabolically Fit for the Long Haul
Delgoffe, G. M. (2016) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-16-0244 · Cited by 26
Lameirinhas, A., Miranda‐Gonçalves, V., Henrique, R., & Jerónimo, C. (2019) · Genes · doi:10.3390/genes10040264 · Cited by 28
Analysis of Expression Patterns of MicroRNAs That Are Closely Associated With Renal Carcinogenesis
Shiomi, E., Sugai, T., Ishida, K., Osakabe, M., Tsuyukubo, T., Kato, Y., Takata, R., & Obara, W. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.00431 · Cited by 25
Rao, H., Li, X., Liu, M., Liu, J., Feng, W., Tang, H., Xu, J., Gao, W., & Li, L. (2021) · Cancer Research · doi:10.1158/0008-5472.can-20-3960 · Cited by 25
Sullivan, D. K., Deutzmann, A., Yarbrough, J., Krishnan, M. S., Gouw, A. M., Bellovin, D. I., Adam, S. J., Liefwalker, D. F., Dhanasekaran, R., & Felsher, D. W. (2022) · Oncogene · doi:10.1038/s41388-022-02458-9 · Cited by 26
Self-citationEBF1, PAX5, and MYC: regulation on B cell development and association with hematologic neoplasms
Li, L., Zhang, D., & Cao, X. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1320689 · Cited by 24
GLUD1 suppresses renal tumorigenesis and development via inhibiting PI3K/Akt/mTOR pathway
Wang, L., Fang, Z., Gao, P., & Zheng, J. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.975517 · Cited by 24
Cao, Y., Wang, J., Hou, W., Ding, Y., Zhu, Y., Zheng, J., Huang, Q., Cao, Z., Xie, R., Wei, Q., et al. (2023) · Gut Microbes · doi:10.1080/19490976.2023.2263934 · Cited by 24
SIRT1 regulates Mxd1 during malignant melanoma progression
Meliso, F. M., Micali, D., Silva, C. T., Sabedot, T. S., Coetzee, S. G., Koch, A., Fahlbusch, F. B., Noushmehr, H., Schneider‐Stock, R., & Jasiulionis, M. G. (2017) · Oncotarget · doi:10.18632/oncotarget.21457 · Cited by 24
Classification of High-Grade Serous Ovarian Cancer Using Tumor Morphologic Characteristics
Handley, K. F., Sims, T. T., Bateman, N. W., Glassman, D., Foster, K. I., Lee, S., Yao, J., Yao, H., Fellman, B. M., Liu, J., et al. (2022) · JAMA Network Open · doi:10.1001/jamanetworkopen.2022.36626 · Cited by 23
Self-citationZhang, J., Chen, M., Yang, Y., Liu, Z., Guo, W., Xiang, P., Zeng, Z., Wang, D., & Xiong, W. (2024) · Journal of Cellular Physiology · doi:10.1002/jcp.31349 · Cited by 23
Neuß, T., Chen, M.-C., Wirges, N., Usluer, S., Oellinger, R., Lier, S., Dudek, M., Madl, T., Jastroch, M., Steiger, K., et al. (2024) · Cancer Research · doi:10.1158/0008-5472.can-23-2213 · Cited by 23
Steven, R. T., Niehaus, M., Taylor, A. J., Nasif, A., Elia, E. A., Goodwin, R. J. A., Takáts, Z., & Bunch, J. (2022) · Analytical Chemistry · doi:10.1021/acs.analchem.2c00690 · Cited by 23
Circular RNAs function as competing endogenous RNAs in multiple types of cancer (Review)
Ji, Q., Zhang, C., Sun, X., & Li, Q. (2017) · Oncology Letters · doi:10.3892/ol.2017.7348 · Cited by 22
Metabolic reprogramming and metabolic sensors in KSHV-induced cancers and KSHV infection
Li, T., & Gao, S. (2021) · Cell & Bioscience · doi:10.1186/s13578-021-00688-0 · Cited by 21
Banerjee, S., Wong, A. C.-Y., Yan, X., Wu, B., Zhao, H., Tibshirani, R. J., Zare, R. N., & Brooks, J. D. (2019) · Scientific Reports · doi:10.1038/s41598-019-47396-x · Cited by 21
Self-citationPham, K., Hanaford, A. R., Poore, B., Maxwell, M. J., Sweeney, H., Parthasarathy, A., Alt, J., Rais, R., Slusher, B. S., Eberhart, C. G., et al. (2022) · Cancers · doi:10.3390/cancers14051311 · Cited by 21
Huang, J., Kong, W., Zhang, J., Chen, Y., Xue, W., Liu, D., & Huang, Y. (2016) · International Journal of Oncology · doi:10.3892/ijo.2016.3622 · Cited by 21
Modification in Structures of Active Compounds in Anticancer Mitochondria-Targeted Therapy
Felczykowska, A., & Herman-Antosiewicz, A. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26031376 · Cited by 21
Hunt, J. P., Barnett, R. J., Robinson, H., Soltani, M., Nelson, J. A., & Bundy, B. C. (2020) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2020.09.011 · Cited by 20
Koça, D., Séraudie, I., Jardillier, R., Cochet, C., Filhol, O., & Guyon, L. (2023) · Cancers · doi:10.3390/cancers15102701 · Cited by 19
Ciombor, K. K., Bae, S.-W., Whisenant, J. G., Ayers, G. D., Sheng, Q., Peterson, T. E., Smith, G. T., Lin, K., Chowdhury, S., Marie, P. K., et al. (2025) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-24-3133 · Cited by 19
Jirásko, R., Idkowiak, J., Wolrab, D., Kvasnička, A., Friedecký, D., Polański, K., Študentová, H., Študent, V., Melichar, B., & Holčapek, M. (2022) · Cancers · doi:10.3390/cancers14194622 · Cited by 19
An updated patent review of glutaminase inhibitors (2019–2022)
Wang, D., Li, X., Gong, G., Lu, Y., Guo, Z., Chen, R., Huang, H., Li, Z., & Bian, J. (2023) · Expert Opinion on Therapeutic Patents · doi:10.1080/13543776.2023.2173573 · Cited by 18
Metabolomics in renal cell carcinoma: From biomarker identification to pathomechanism insights
Chen, Y., Hu, H.-H., Wang, Y., Liu, J., Liu, H., Liu, J., & Zhao, Y. (2020) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2020.108623 · Cited by 18
Analysis of the Myc-induced pancreatic β cell islet tumor microenvironment using imaging ToF-SIMS
Bluestein, B. M., Morrish, F. M., Graham, D. J., Huang, L., Hockenbery, D. M., & Gamble, L. J. (2018) · Biointerphases · doi:10.1116/1.5038574 · Cited by 17
Schmid, V., Lafleur, V. N., Lombardi, O., Li, R., Salama, R. A., Colli, L. M., Choudhry, H., Chanock, S. J., Ratcliffe, P. J., & Mole, D. R. (2019) · Scientific Reports · doi:10.1038/s41598-019-55098-7 · Cited by 17
Identification of anti-tumoral feedback loop between VHLα and hnRNPA2B1 in renal cancer
Liu, Y., Zhang, H., Li, X., Zhang, C., & Huang, H. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-02861-8 · Cited by 17
Yegambaram, M., Sun, X., Lü, Q., Flores, A. G., Zemskova, M., Soto, J. E., Rauckhorst, A. J., Maltepe, E., Wang, T., Fineman, J. R., et al. (2025) · Redox Biology · doi:10.1016/j.redox.2025.103765 · Cited by 17
Targeting ferroptosis and ferritinophagy: new targets for cardiovascular diseases
Luan, Y., Yang, Y., Luan, Y., Liu, H., Han, X., Pei, J., Liu, H., Qin, B., & Ren, K. (2024) · Journal of Zhejiang University SCIENCE B · doi:10.1631/jzus.b2300097 · Cited by 16
Clemente, V., Hoshino, A., Shetty, M., Nelson, A., Erickson, B. K., Baker, R., Rubin, N., Khalifa, M. A., Weroha, S. J., Lou, E., et al. (2022) · Cancer Research Communications · doi:10.1158/2767-9764.crc-22-0122 · Cited by 16
Monteith, A. J., Ramsey, H. E., Silver, A. J., Brown, D. J., Greenwood, D. L., Smith, B. N., Wise, A. D., Liu, J., Olmstead, S. D., Watke, J., et al. (2024) · Cancer Research · doi:10.1158/0008-5472.can-23-0291 · Cited by 17
RGS19 activates the MYH9/β-catenin/c-Myc positive feedback loop in hepatocellular carcinoma
Ke, S., Lu, S., Xu, Y., Bai, M., Yu, H., Yin, B., Wang, C., Feng, Z., Li, Z., Huang, J., et al. (2024) · Experimental & Molecular Medicine · doi:10.1038/s12276-024-01244-9 · Cited by 15
Alfaifi, A., Bahashwan, S., Alsaadi, M., Malhan, H. M., Aqeel, A., Al-Kahiry, W., Almehdar, H. A., & Qadri, I. (2022) · Diagnostics · doi:10.3390/diagnostics12020394 · Cited by 17
Yang, J., Miao, D., Li, X., Zhao, C., Tan, D., Wu, S., Lu, F., Shi, J., Lv, Q., Ruan, H., et al. (2025) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2025.1664292 · Cited by 15
Caliskan, A., Andac, A. C., & Arğa, K. Y. (2020) · Genomics · doi:10.1016/j.ygeno.2020.06.003 · Cited by 14
Metabolic vulnerabilities of MYC-induced cancer
Gouw, A. M., Toal, G. G., & Felsher, D. W. (2016) · Oncotarget · doi:10.18632/oncotarget.7223 · Cited by 14
Self-citationKing, M. E., Yuan, R. T., Chen, J., Pradhan, K., Sariol, I., Li, S. X., Chakraborty, A. D., Ekpenyong, O., Yearley, J. H., Wong, J. C., et al. (2023) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2023.102902 · Cited by 16
Self-citationBiomolecular condensates in kidney physiology and disease
Gao, G., Sumrall, E. R., Pitchiaya, S., Bitzer, M., Alberti, S., & Walter, N. G. (2023) · Nature Reviews Nephrology · doi:10.1038/s41581-023-00767-0 · Cited by 15
Regucalcin Is a Potential Regulator in Human Cancer: Aiming to Expand into Cancer Therapy
Yamaguchi, M. (2023) · Cancers · doi:10.3390/cancers15225489 · Cited by 13
Thng, D. K. H., Toh, T. B., Pigini, P., Hooi, L., Dan, Y. Y., Chow, P. K. H., Bonney, G. K., Rashid, M. B. M. A., Guccione, E., Wee, D. K. B., et al. (2022) · Bioengineering & Translational Medicine · doi:10.1002/btm2.10363 · Cited by 13
Maroto, P., Esteban, E., Parra, E. F., Mendez-Vidal, M., Domènech, M., Pérez‐Valderrama, B., Calderero, V., Perez‐Gracia, J. L., Grande, E., & Ferran Algaba, B. (2017) · OncoTargets and Therapy · doi:10.2147/ott.s137677 · Cited by 13
da Silva, R. L. C. G., da Silva, H. F. O., Gasparotto, L. H. S., & Caseli, L. (2018) · Biophysical Chemistry · doi:10.1016/j.bpc.2018.04.007 · Cited by 13
Yamaguchi, M., Osuka, S., Hankinson, O., & Murata, T. (2018) · International Journal of Oncology · doi:10.3892/ijo.2018.4611 · Cited by 13
Hubbard, K. E., Dunbar, S. D., Peasland, E. L., Poon, J., & Solly, J. E. (2022) · International Journal of Science Education, Part B · doi:10.1080/21548455.2022.2078010 · Cited by 12
Khalid, K. M., Ratnayake, W. S., Apostolatos, C., & Acevedo-Duncan, M. E. (2024) · Frontiers in Oncology · doi:10.3389/fonc.2023.1213715 · Cited by 12
Lipid Metabolic Reprogramming in Embryonal Neoplasms with MYCN Amplification
Talapatra, J., & Reddy, M. M. (2023) · Cancers · doi:10.3390/cancers15072144 · Cited by 12
Pawlak, M., Kikulska, A., Wrzesiński, T., Rausch, T., Kwias, Z., Wilczyński, B., Beneš, V., Wesoły, J., & Wilanowski, T. (2017) · Molecular Carcinogenesis · doi:10.1002/mc.22682 · Cited by 12
Metabolic characteristics in hepatocellular carcinoma: amino acid metabolic reprogramming
Zhou, R., Li, Y., Li, G., Li, Y., Luo, L., Wang, B., & Wang, L. (2026) · Molecular Cancer · doi:10.1186/s12943-025-02492-7 · Cited by 11
Self-citationGlutaminolysis is a Potential Therapeutic Target for Kidney Diseases
Ou, L., Liu, Y., Qiu, S.-T., Yang, C., Tang, J., Li, X., Liu, H., & Ye, Z.-N. (2024) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s471711 · Cited by 11
Bellut, J., Bertz, S., Nolte, E., Stöhr, C., Polifka, I., Lieb, V., Herrmann, E., Jung, R., Hartmann, A., Wullich, B., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-16144-4 · Cited by 11
Stomach-specific c-Myc overexpression drives gastric adenoma in mice via AKT/mTOR signaling
Liu, J., Feng, W., Liu, M., Rao, H., Li, X., Teng, Y., Yang, X. Y., Xu, J., Gao, W., & Li, L. (2020) · Bosnian Journal of Basic Medical Sciences · doi:10.17305/bjbms.2020.4978 · Cited by 11
Metabolic convergence on lipogenesis in RAS, BCR-ABL, and MYC-driven lymphoid malignancies
Liefwalker, D. F., Gabay, M., Wang, Z., Pathak, K. V., Plaisier, S. B., Shah, V. M., Babra, B., Dewson, G. S., Lai, I. K., Mosley, A. R., et al. (2021) · Cancer & Metabolism · doi:10.1186/s40170-021-00263-8 · Cited by 12
Self-citationFerreira, W. A. S., & de Oliveira, E. H. C. (2022) · Current Issues in Molecular Biology · doi:10.3390/cimb44060169 · Cited by 13
Vízkeleti, L., & Spisák, S. (2023) · Cells · doi:10.3390/cells12131745 · Cited by 10
STAG2 inactivation reprograms glutamine metabolism of BRAF-mutant thyroid cancer cells
Li, X., Liu, Y., Liu, J., Qiang, W., Ma, J., Xie, J., Chen, P., Wang, Y., Hou, P., & Ji, M. (2023) · Cell Death and Disease · doi:10.1038/s41419-023-05981-z · Cited by 10
Thiol starvation triggers melanoma state switching in an ATF4 and NRF2-dependent manner
Meinert, M., Jessen, C., Hufnagel, A., Kreß, J. K. C., Burnworth, M., Däubler, T., Gallasch, T., da Silva, T. N. X., dos Santos, A. F., Ade, C. P., et al. (2023) · Redox Biology · doi:10.1016/j.redox.2023.103011 · Cited by 10
The role of metabolic reprogramming in kidney cancer
Chen, Z., & Zhang, X. (2024) · Frontiers in Oncology · doi:10.3389/fonc.2024.1402351 · Cited by 11
Zhao, Q., Kun, D., Hong, B., Deng, X., Guo, S. J., Tang, X., Yang, Y., Gong, K., Li, Q., Ye, L., et al. (2017) · Anticancer Research · doi:10.21873/anticanres.11832 · Cited by 10
Yang, L., Cui, Y., Liang, L., & Lin, J. (2023) · Thoracic Cancer · doi:10.1111/1759-7714.14888 · Cited by 9
Lipid metabolism reprogramming in renal cell carcinomas
Abduljabbar, M. K., Merza, M., Aziz, A., Menon, S. V., Kaur, M., Aminov, Z., Rab, S. O., Hjazi, A. M., Mustafa, Y. F., & Gabel, B. C. (2024) · Medical Oncology · doi:10.1007/s12032-024-02484-5 · Cited by 9
MYC at the tumor–immune interface: mechanisms of immune escape and immunotherapy resistance
González-Larreategui, Í., Martin, M. C., Casacuberta‐Serra, S., & Soucek, L. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1738440 · Cited by 10
Balakrishnan, K., & Ganesan, K. (2022) · Medical Oncology · doi:10.1007/s12032-022-01717-9 · Cited by 9
Application of Metabolic Reprogramming to Cancer Imaging and Diagnosis
Yang, Y., Li, C., Cai, H.-Y., Lin, B.-S., Kim, C., & Chang, Y. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232415831 · Cited by 9
Targeting Metabolic Pathways in Kidney Cancer
Hoerner, C. R., Miao, S. Y., Hsieh, J. J.-D., & Fan, A. C. (2020) · The Cancer Journal · doi:10.1097/ppo.0000000000000472 · Cited by 9
Crosstalk of glutamine metabolism between cancer-associated fibroblasts and cancer cells
Chen, T., Xu, Y., Yang, F., Pan, Y., Ji, N., Li, J., Zeng, X. Y., Chen, Q., Jiang, L., & Shen, Y. (2025) · Cellular Signalling · doi:10.1016/j.cellsig.2025.111874 · Cited by 9
Li, B., Yao, B., Guo, X., Wang, Z., Xie, W., Wu, X., Wang, F., & Mei, Y. (2023) · Cancer Gene Therapy · doi:10.1038/s41417-023-00631-0 · Cited by 8
Lee, Y. M., Kim, M. J., Kim, Y., & Kim, H. (2015) · Journal of Cancer Prevention · doi:10.15430/jcp.2015.20.3.179 · Cited by 8
Nelson, L. J., Castro, K. E., Xu, B., Li, J., Dinh, N. B., Thompson, J. M., Woytash, J., Kipp, K. R., & Razorenova, O. V. (2022) · Cell Cycle · doi:10.1080/15384101.2022.2041783 · Cited by 8
Hönscheid, P., Baretton, G. B., Puhr, M., Siciliano, T., Israel, J. S., Stope, M. B., Ebersbach, C., Beier, A.-M. K., Thomas, C., & Erb, H. H. H. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25179275 · Cited by 7
Wang, J., Yang, W., Li, X., Xu, B., Yang, Y., Zhang, B., Dai, C.-M., & Feng, J. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2022.996248 · Cited by 7
Pan, X., Chen, W., Xu, D., Guan, W., Li, L., Chen, J., Chen, W., Dong, K., Ye, J., Gan, S., et al. (2023) · iScience · doi:10.1016/j.isci.2023.108370 · Cited by 7
Krencz, I., Vetlényi, E., Dankó, T., Petővári, G., Moldvai, D., Sztankovics, D., Raffay, R. E., Mészáros, K. V., Sebestyén, E., Végső, G., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231810587 · Cited by 7
Xie, J., Ni, F., Shao, J., Zhang, D., Guo, T., & Wang, X. W. (2026) · Cancer Letters · doi:10.1016/j.canlet.2026.218244 · Cited by 6
Rad, N. K., Vahidyeganeh, M., Mohammadi, M., Shpichka, A. I., Timashev, P. S., Hossein‐Khannazer, N., & Vosough, M. (2022) · International Journal of Translational Medicine · doi:10.3390/ijtm2040042 · Cited by 6
Extracellular Regucalcin: A Potent Suppressor in the Cancer Cell Microenvironment
Yamaguchi, M. (2025) · Cancers · doi:10.3390/cancers17020240 · Cited by 6
JS-K induces ferroptosis in renal carcinoma cells by regulating the c-Myc-GSTP1 Axis
Zhao, Y., Zhu, L., Lin, X., Li, B., Miu, B., Qiu, J., Gao, S., & Liu, J. (2025) · Scientific Reports · doi:10.1038/s41598-025-97887-3 · Cited by 6
Metabolic control of cancer progression as novel targets for therapy
Talukdar, S., Emdad, L., Gogna, R., Das, S. K., & Fisher, P. B. (2021) · Advances in cancer research · doi:10.1016/bs.acr.2021.06.002 · Cited by 6
Metadata
- Authors
- Shroff, E. H., Eberlin, L. S., Dang, V. M., Gouw, A. M., Gabay, M., Adam, S. J., Bellovin, D. I., Tran, P. T., Philbrick, W. M., Garcia-Ocana, A., Casey, S. C., Li, Y., Dang, C. V., Zare, R. N., & Felsher, D. W.
- Affiliations
- Division of Medical Oncology, Departments of Medicine and Pathology, and
- Department of Chemistry, Stanford University School of Medicine, Stanford, CA 94305;
- Abramson Cancer Center (US)
- Johns Hopkins University (US)
- Yale University (US)
- Diabetes, Obesity and Metabolism Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029
- Stanford Medicine (US)
- ORCID
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2015-05-11
- Volume
- 112
- Issue
- 21
- Pages
- 6539-6544
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC4450371
- OpenAlex
- W1772301402
- Cited by
- 255
- References
- 64
- Citations by year
- 2026: 11 · 2025: 22 · 2024: 23 · 2023: 22 · 2022: 34 · 2021: 24 · 2020: 29 · 2019: 18 · 2018: 22 · 2017: 26 · 2016: 20 · 2015: 4
- FWCI
- 7.93
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- HHS | National Institutes of Health (CA 089305, 105102, 170378)
- HHS | NIH | National Cancer Institute (CA 114747, CA 112973, U01 CA188383, CA034233, CA 184384)
- Leukemia and Lymphoma Society (R6223-07)
- American Lung Association (RT-169741-N)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Health Sciences › Medicine › Oncology › Renal cell carcinoma treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Ferroptosis and cancer prognosis
- Keywords
- MYC oncogene, renal cell carcinoma, glutamine metabolism, glutaminolysis, oncogenic Ras, tumor progression, cancer metabolism, desorption electrospray ionization mass spectrometry imaging
- MeSH terms
- Animals, Carcinoma, Renal Cell, Disease Models, Animal, Enzyme Inhibitors, Glutaminase, Glutamine, Humans, Kidney Neoplasms, Mice, Transgenic, Genes, ras, RNA, Messenger, RNA, Neoplasm, Sulfides, Thiadiazoles, Up-Regulation, Genes, myc, Mice, SCID, Disease Progression, Spectrometry, Mass, Electrospray Ionization, Cell Line, Tumor, Lipid Metabolism, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
